DR. WISAM BREEGI, FOUNDER AND CEO
Dr. Breegi is founder and chief executive officer of Breegi Scientific and serves on the Board of Directors. He is an inventor, entrepreneur and human rights activist, with over 25 years of management and diverse preclinical and research experience covering a wide range of medical fields, in addition to extensive clinical expertise. He served as director of in vivo research programs in several biotechnology companies, in addition to working in academic institutions. He is currently a guest lecturer at Boston University.
His career is built on innovation and social justice for the disadvantaged, stemming from his upbringing and education, with a unique perspective of certain medical issues and challenges. He successfully led preclinical programs in ophthalmology, cancer and gastroenterology, while inventing several methods and devices such as in the field of sustained ophthalmic drug delivery. He is the inventor of SteriDome™, a platform technology for controlled microenvironments.
Dr. Breegi was a National Institute of Health postdoctoral fellow at Tufts University School of Medicine in Gastroenterology. He received his veterinary medicine degree from Baghdad University and was awarded his first patent in 1988. He deeply understands the suffering of people, which reflects in the philosophy of Breegi Scientific, as well as his work. He has invented several medical devices and published methods. In addition, Dr. Breegi is involved in many humanitarian projects that touched directly thousands of people.
JASON WALSH, VICE PRESIDENT OF OPERATIONS
Mr. Walsh leads finance, operations and corporate development activities for Breegi Scientific. He brings more than twenty years of leadership experience in life science organizations. He is the founder and Managing Partner of Great Brook Biotech, a boutique new venture and business development consultancy for start-up biotechnology and medical device companies. Prior to Great Brook Biotech, Mr. Walsh was Chief Financial Officer for Global Enterprise Services Corporation, a global consulting company building infrastructure projects in Sub-Saharan Africa.
Mr. Walsh was a co-founder, Director, and Chief Business Officer of Provenance Biopharmaceuticals Corp., a clinical stage cancer immunotherapy company. Previously, Mr. Walsh was Senior Director of Finance and Business Operations for Lexigen Pharmaceuticals Corp. Earlier in his career, Jason founded and led several entrepreneurial ventures in a wide range of industries. Mr. Walsh has his MBA from Babson College and his B.S. degree from the University of Massachusetts.
DANNY BREEGI, DIRECTOR OF GLOBAL HEALTH
Danny Breegi holds a Master degree at Boston University's School of Public Health with a concentration in global health and medical products. He brings a passion for developing groundbreaking strategies and methods to solve the most prevalent issues in global health as an active participant in community health initiatives locally and internationally. Danny's work in Breegi Scientific reflects these goals by creating comprehensive solutions for today's most at-risk local and international communities by finding the common flaws of health care throughout the global health landscape.
DR. LUTHER HARRY CASTILLO, DIRECTOR OF INTERNATIONAL DEVELOPMENT
Dr. Castillo is a founder of El Primer Hospital Popular de Garifuna, a rural hospital in eastern Honduras serving the Garifuna ethnic community. He wrote the current public health policy of Honduras and is currently pioneering alternative healthcare models for low-resource communities, such as his native Garifuna ethnic tribe. A Harvard Kennedy School alumnus, Dr. Castillo is one of the most active public health officials in Central and Latin America, and splits his time between attending academic events around North and Latin America, and spending the remainder of his time in rural Honduras developing his clinics. He is a medical doctor with an MPH from Harvard University has significant experience in LMICs. He is a government expert on low resource and child healthcare issues. He is passionate about promoting medical innovation in rural Honduras and in indigenous communities such as the Garifuna people. He is former Commissioner of Health in Honduras and was commissioned by the President for writing the National Healthcare Reform.
ANH NGUYEN, HEAD OF RESEARCH AND DEVELOPMENT
Mr. Anh Nguyen, Head of Research and Development - is a biomedical engineer with over 20 years of product design and medical product development experience for several multi-million dollar projects. An integrity-driven engineering manager with a record of program successes and the ability to assemble a highly effective team to resolve difficult issues and manage resources to generate on-time and on-budget deliverables. Anh has a proven ability to effectively communicate with program personnel and management. His leadership and management skills to define strategies to achieve success in research and development programs have accelerated Breegi Scientific into a global medical market.
EL-WALID AL-BERMANI, MD, PHD.
Dr. El-Bermani serves at the scientific advisory board. He is a professor at the Department of Anatomy and Cellular Biology, Tufts University School of Medicine. He taught anatomy and physiology for over 35 years. He directed and co-directed several programs such as Surgical Anatomy Neuro-ophthalmology, Emergency Medicine, Emergency Hand Trauma workshop, Reconstructive Surgical Anatomy, Development of reconstructive surgical procedures for wounded Vietnam veterans.
CLAIR STROHL, BS, MS, MBA
Mr. Clair Strohl has extensive experience in the new medical plastic, regulation FDA and manufacturing implementation processes and IP. He has engineered products including implantable cardiac assist devices, blood processing disposables, urological collection systems, IV infusions, ostomy and vascular access devices, and ultrasonic and radiological accessories. Clair received more than a dozen issued patents and several publications.
BOARD OF DIRECTORS
Clair Strohl, BS, MS, MBA
El-Walid Al-Bermani, MD, PhD.